Last reviewed · How we verify
anti-diabetic herbal drug — Competitive Intelligence Brief
marketed
Diabetes
Small molecule
Live · refreshed every 30 min
Target snapshot
anti-diabetic herbal drug (anti-diabetic herbal drug) — Kerman Medical University. An herbal formulation that improves blood glucose control through multiple plant-derived bioactive compounds with insulin-sensitizing and glucose-regulating properties.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| anti-diabetic herbal drug TARGET | anti-diabetic herbal drug | Kerman Medical University | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- anti-diabetic herbal drug CI watch — RSS
- anti-diabetic herbal drug CI watch — Atom
- anti-diabetic herbal drug CI watch — JSON
- anti-diabetic herbal drug alone — RSS
Cite this brief
Drug Landscape (2026). anti-diabetic herbal drug — Competitive Intelligence Brief. https://druglandscape.com/ci/anti-diabetic-herbal-drug. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab